InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+42.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Thero John F, Chief Executive Officer. Director active across 2 companies, notably Amarin CORP Plc\uk. In total, 10 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €19k. History available since 10 May 2022. The latest transaction was filed on 8 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Thero John F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
12,828 shares@ US$1.6951.4% of flowCommon StockSEC:0001209191-24-003090:0
10,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001209191-22-028578:0
Canonical exit: 8 Aug 2022 (T+90)
6,736 sharesOrdinary SharesSEC:0001562180-21-005143:0
6,736 sharesOrdinary SharesSEC:0001562180-21-004737:0
6,736 sharesOrdinary SharesSEC:0001562180-21-003848:0
25,000 sharesOrdinary SharesSEC:0001209191-16-095108:0
Canonical exit: 1 May 2016 (T+90)
169,500 sharesOrdinary SharesSEC:0001209191-16-094735:0
260,000 sharesOrdinary SharesSEC:0001209191-16-094735:1
172,157 sharesOrdinary SharesSEC:0001209191-16-094735:2
37,500 sharesOrdinary SharesSEC:0001209191-16-087894:0
10 of 10 declarations
About Thero John F
THERO JOHN F is Président et Directeur Général. The declarant has 10 filings in total. Among the recent filings we hold, they span 2016-01-04 to 2024-02-12, with total buys of EUR 18988 and no reported sell total; the most common transaction nature is Levée d'options. They are linked to Amarin CORP Plc\uk, where the listed role is President and CEO, and to Cyteir Therapeutics, Inc., where the listed role is Director.
